Zhijie Ding

Zhijie Ding currently serves as Associate Director of CORE within Global Medical Affairs at Genmab, focusing on the evidence generation and dissemination strategies for epcoritamab. Prior experience includes over seven years at The Janssen Pharmaceutical Companies of Johnson & Johnson, where Zhijie held multiple Associate Director roles, contributing to real-world evidence strategies for IMBRUVICA® and STELARA®, along with a managerial position in Health Economics and Outcomes Research. Zhijie's early career involved research leadership in breast cancer at the University of Pittsburgh Drug Discovery Institute and a postdoctoral fellowship with the American Heart Association. Educational qualifications include an MBA in Marketing and Management from Indiana University's Kelley School of Business, a PhD in Bioengineering, an MS in Health Services Research and Policy from the University of Pittsburgh, and a BS in Life Sciences from Fudan University.